Did you miss this event in November? Check it out now below. Want the CE credit? Jump over to VetCE On Demand at VetMedTeam afterward and complete the quiz. Don't forget – as a VPN Plus+ member you get a discount for VetMedTeam courses; visit the Education page to get your promo code. Are you a VPN Plus+ Premium member? You get VetCE On Demand courses for free! Visit your account page to get the link. And don't forget to check out the next VetCE Virtual Live event; visit vetce.events to learn more. Craig Clifford, DVM, MS, DACVIM (Oncology), graduated from Mississippi State University College of Veterinary Medicine and received an MS in Animal Science/Virology from the University of Delaware. After completing an internship and a medical oncology residency at the University of Pennsylvania, he became a diplomate of the American College of Veterinary Internal Medicine (Oncology) in 2003. He is a medical oncologist at BluePearl Malvern and was previously the director of BluePearl Science. He is active in clinical research within a referral setting and serves as an advisory board member with industry and non-profit foundations. He has authored/co-authored more than 70 papers and book chapters and is a frequent lecturer at major veterinary meetings in the USA and abroad. Dr. Clifford is a member of the Mars Veterinary Oncology Advisory Board, has served on many VCS and ACVIM committees, is a member of the Oncology Pathology Working Group, and was an examiner for the Australian Scientist’s Oncology Specialty Exam. Veterinary oncology has seen significant advancements in immunotherapy, offering novel treatment approaches for companion animals diagnosed with cancer. Immunotherapy aims to harness the body’s immune system to recognize and attack cancerous cells, reducing reliance on traditional treatments such as chemotherapy and radiation therapy. In this session: Craig Clifford, DVM, MS, DACVIM (Oncology) discusses key immunotherapeutic strategies, available products, and clinical advancements in veterinary oncology.
